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I Comparison of Estradiol-Trenbolone Acetate Implant Programs for Yearling Steers of Two Genotypes 
Summary 
SDSU 
Yearling steers (n = 400) were used to 
evaluate relative payout periods for implants 
when feeding high grain content diets. Implant 
treatments included (1) control (nonimplanted), 
(2) Synovex Plus, (3) revalor-S, and (4) Ralgro- 
revalor-S. The Synovex Plus (2), revalor-S (3) 
and Ralgro (4) were administered on day 1. The 
reimplant with revalor-s (4) was admnistered 
after 56 d on feed. Steers were managed in two 
groups. Initial BW and days fed were 782 Ib, 131 
d (Group I), and 661 Ib, 145 d (Group 11). 
Implants increased production rates and 
efficiencies, increased carcass size and reduced 
marbling when compared to nonimplanted 
controls. Production rates and efficiencies and 
carcass sizes were similar among steers that 
received implants. Marbling scores and 
percentage choice carcasses were affected by 
implants. In general, the delayed use of an 
estradiol-trenbolone acetate implant improved 
marbling over d 1 implanting even though there 
were 56 fewer days on feed after implanting. 
The energy density of live weight gain was 
calculated over the course of the feeding period 
based upon interim period BW and DM1 
determinations. Higher energy content of gain 
early in the feeding period for treatments 1 and 4 
were related to marbling, while the energy 
content of gain late in feeding period was not. 
These data showed no differences in the relative 
effective duration of Synovex Plus and revalor-S 
implants. The influence of implants on carcass 
quality grades was affected by factors other than 
elapsed time from implanting to harvest. 
Robbi H. ~ritchard' 
Department of Animal and Range Sciences 
CATTLE 00-10 
Introduction 
Optimizing implant strategies requires 
striking a balance between implant payout, 
production costs, and carcass specifications. 
1 Professor 
2~oechst Roussel Agri Vet 
The influence of implants on cost of gain erodes 
over time. This encourages shortening the 
expected payout of the implant. However, it is 
generally considered that carcass marbling is 
increased as the elapsed time from implanting to 
slaughter is increased. The label associated 
with implant clearances generally does not 
stipulate how prolonged exposure to the implant 
relates to these conflicting variables. 
Presently there are two estradiol-trenbolone 
acetate implant formulations available for use in 
steers being fed for slaughter. One product 
provides 24 mg estradiol and 120 mg trenbolone 
acetate. A second available product provides 
the equivalent of 20 mg estradiol as estradiol 
benzoate and 200 mg trenbolone acetate. 
These are potent tools for improving production 
rates in steers. The concentration and 
proportion of active ingredients in these implants 
differ as does the carrier matrix. This 
experiment was designed to compare the 
relative payout of these products. The 
information is intended to help producers define 
the time exposure appropriate for their 
production constraints. 
To evaluate effective payout, it is 
advantageous to have a nonimplanted control to 
use as a reference point during growth. It would 
also be advantageous to have a positive control 
that provides high levels of implant payout 
during the same time frame associated with the 
expected depletion of the test implant(@. This 
could be accomplished by administering 
implants in a staggered time schedule in the 
positive control treatment. Coincidentally, this 
would also allow consideration of a re-implant 
program. 
In the experiment described here we wished 
to evaluate the relative effective payout for 
revalor-s2 (20 mg estradioV120 mg trenbolone 
acetate) and Synovex plus3 (28 mg estradiol 
benzoate1200 mg trenbolone acetate). 
Nonimplanted steers were used as the negative 
control. The positive control involved delaying 
revalor-S implanting for 56 d to provide a 
staggered payout during the later stages of the 
feeding period. In the positive control ~ a l g r o ~  
(36 mg zeranol) was used to provide growth 
promoting activity during the initial 56 d on feed. 
The implant strategies used included (1) Control 
(nonimplanted); (2) Synovex Plus; (3) revalor-S; 
and (4) Ralgro-revalor-S. The Synovex Plus (2), 
revalor-S (3), and Ralgro (4) were administered 
on day 1. The re-implant with revalor-S (4) was 
administered after 56 d on feed. 
Forty pens of 10 steers were assigned to the 
experiment. Steers were purchased as two 
major groups. Group I consisted primarily of 
black hided steers and Group II was 
predominately continental crosses. Each group 
provided enough steers to fill 20 pens (5 pens 
per implant treatment per group). The groups 
were fed and managed as distinctive lots of 
cattle to accommodate differences in implant 
response and marketing needs that could occur 
between differing biological types. The nutrition, 
processing and implant management was 
common across groups. Days on feed were 131 
for Group I and 145 for Group II. 
The 200 steers used in Group I were 
selected from a group of 223 steers. The Group 
II steers (n=200) were drawn from a pool of 234 
steers. At arrival cattle were observed for 
thriftiness, structural soundness and type 
characteristics. Any unacceptable subjects were 
deleted. Within a source group, cattle were 
ranked by arrival BW and outliers were deleted. 
Once the pool was reduced to 200 subjects, 
treatment was assigned (1 to 4) using a random 
sequence of treatment codes. Data were 
resorted by treatment and BW and assigned a 
random sequence of replicate codes. The 
treatment-replicate combinations were then 
assigned pen numbers such that treatment was 
randomly distributed throughout the 20 pens 
allocated to the group. This allotment system 
distributed BW ranges similarly in all pens. 
' ~ t .  Dodge Animal Health, 
'schering Plough 
'~rnithklim, Beecham 
Starting dates were May 1, 1996, for Group I 
and May 23, 1996, for Group II. 
Incoming cattle were eartagged and then 
vaccinated for IBR, BVD, PI3, BRSV, H. somnus 
and 7 clostridial SP using Ultrabac 7 and 
Resvac 41somu bacs. Parasite control was 
provided by administering ~ x p a r ~  (external) and 
~anacu? (internal) according to label 
instructions. During processing, ears were 
palpated for evidence of viable implants. None 
were found. During the receiving period long 
hay and the step 1 diet (Table 1) were fed. The 
milled feed delivery was limited to 1.5% BW 
during receiving (3 or 4 d). 
Initial and final individual BW each were 
recorded on two consecutive days. Initial 
implants were administered during the second 
initial BW processing. Re-implanting with 
revalor-S was done during the d 56 BW 
processing. Implant integrity was evaluated at 
the next weigh day following implanting. Interim 
BW was determined as noted in Table 2. All BW 
were collected with no prior restriction of feed or 
water. 
Cattle were fed twice daily. A five step 
program was used to adapt cattle to the finishing 
diet (Table 1). Feed calls were made daily at 
0700 based on bunk and cattle condition. A 
clean bunk management system was used. 
Rations were mixed using a stationary mixer. A 
single batch of feed was distributed within 
replicate so that implant treatment and feed 
batch were not confounded. Samples of feed 
ingredients were collected once each week. 
The analyses of these samples were combined 
with batching records to reconstruct the 
composition of diets fed. While on step 5, these 
diets contained DM 75.5% * .5, CP 12.4% * .07, 
ADF 5.6% * .15, NDF 12.6% * .8, and ash 2.7% 
* .04. The estimated final diet energy density 
was NE, 94.8 McaVcwt * .12 and NE, 63.7 
McaVcwt k . lo. All pens were fed the final diet 
(5) within 15 d on trial. These weekly assays 
and feed delivery records were used to produce 
DM1 summaries each week or more frequently 
when necessary. 
Initial and interim BW reported in Table 3 
were not corrected for fill. The final BW referred 
to in Table 3 included a 3% shrink. This shrunk 
BW was used to calculate cumulative ADG and 
dressing percentage. To evaluate the 
performance response to the re-implant 
treatment (4), performance variables were 
summarized for the periods prior to (EARLY) 
and following re-implanting (LATE). The Group I 
cattle were fed for 131 d and the Group II were 
fed for 145 d. This caused the LATE 
performance windows to be 57 to 131 and 57 to 
145 d, for Group I and II, respectively. 
Two steers were removed from the study; 
one for lameness and one suffered apparent 
metabolic disorders. These individuals had 
been individually hospitalized prior to deleting 
them from the study. Their BW contribution to 
the pen mean was deleted from the onset of the 
experiment. Feed records were corrected for 
the days the subjects were hospitalized. It was 
assumed that these individuals consumed pen 
average DM1 up to the point of hospitalization. 
On the evening following the final BW, 
steers were transported 75 miles to the beef 
packing plant at Luveme, MN. They stood 
overnight and were processed at 0700 the 
following day. Individual carcass identity was 
maintained. Hot carcass weight was recorded 
the day of slaughter. Longissimus area, ribfat 
thickness, marbling score, bone maturity, lean 
maturity, KPH (omitted in Group I), and 
masculinity were collected 24 h after 
exsanguination. Data were collected by SDSU 
personnel trained in carcass evaluation. 
One steer was mishandled during transit 
and was not slaughtered as part of this 
experiment. Consequently, carcass data were 
available for 397 subjects. 
All performance variables were evaluated in 
a statistical model that included treatment, 
group, and the treatment x group interaction 
using the GLM package of SAS. The 
experimental unit in these analyses was the pen. 
Orthogonal contrasts were used to separate 
treatments. The contrasts included (a) control 
vs. implants; (b) Synovex Plus and revalor-S vs. 
Ralgro/revalor-S, and (c) Synovex Plus vs. 
revalor-S. Carcass data were handled similarly 
except that the individual steer was considered 
to be the experimental unit. 
The initial BW for Groups I and II were 782 
Ib * 5.5 and 661 Ib * 4.2, respec%vely. The 
predominately Angus x Hereford steers in Group 
I were large framed and had never been 
implanted prior to entering our feedlot. The 
Continental cross steers used in this study were 
smaller framed than the Angus x Hereford 
steers. Initial body condition was not quantified. 
Flesh was considered typical for yearlings 
entering our feedlot. 
Implants increased (P<.001) ADG and DM1 
and reduced feedlgain (P<.OOl ). These 
responses were evident during most interim 
measures of performance (Table 3). In the latter 
stages of feeding period, interactions developed 
between cattle group and implant treatment for 
ADG and feedlgain. The nonimplanted steers in 
Group II were growing more rapidly and more 
efficiently than Group I contemporaries durirlg 
113 to 130 d on feed. These (Group II) steers 
started on feed at a lighter weight and were not 
as close to finish at 130 d. In contrast, the Group 
II steers implanted with Synovex Plus had lower 
ADG at 112 d (3.63 vs. 3.09) and 130 d (3.47 vs. 
2.44) than Group I contemporaries. The DM1 of 
these steers also tended to be lower during 
these interim periods. 
Short intervals between BW measurements 
can be misleading. To average responses 
overtime ADG from 90 to 130 d was calculated 
(Table 3). This approach showed that cattle 
were becoming less efficient as they 
approached hawest BW. A response to 
implanting was still in effect as feedlgain was 
15% lower in steers initially receiving Synovex 
Plus or revalor-S than in nonimplanted steers. 
There was an additional 11% improvement 
(P<.01) in feedlgain during this period in re- 
implanted steers. 
To evaluate the merits of re-implanting, data 
were calculated for 1 to 56 (early) and 57 to final 
(late) feeding periods. During the early phase, 
combination implants caused better ADG and 
feedlgain than Ralgro implants (P<.001). 
Synovex Plus tended (P=.095) to cause higher 
ADG than revalor-S. During the late phase, re- 
implanted steers grew faster (P=.012) and more 
efficiently (P=.006) than single implant steers. 
Interactions existed because the magnitude of 
response to implants differed between groups. 
This may be an artifact of this experiment or that 
cattle respond differently to these implants 
based upon their relative size when implants are 
administered. 
Implants increased hot carcass weight 
(HCW) by 65 Ib. The carcasses produced by 
implanted steers were of comparable weight 
(Table 5). The dressing percentage was 
affected when comparing Synovex Plus and 
revalor-S. This may have been due to 
differences in DM1 at the termination of the 
feedlot study. 
Long issimus area was increased (Pc.001) 
by implants. There was no appreciable 
influence on ribfat thickness. Bone maturity and 
masculinity were increased by implants. Bone 
and lean maturity were greater for re-implanted 
than single implanted cattle, but the magnitude 
of difference is probably inconsequential as 
regards carcass value. 
Influences on marbling were more 
distinctive. Implants reduced marbling scores 
and percentage Choice carcasses (Table 5). 
Marbling scores were lower (Pc.05) for single 
implant strategies (Synovex Plus and revalor-S) 
than the re-implant strategy. These influences 
were more pronounced in the lighter cattle of 
Group ll (Table 6). As was noted earlier 
regarding late gain responses, cattle may be 
responding differently to implants based on their 
relative size when implants are administered. 
A desirable approach to addressing implant 
payout would be to evaluate changes in interim 
period feedlgain. However, fluctuations in 
feedlgain within treatment can occur during 
latter stages of the feeding period. This problem 
becomes exaggerated with short intervals of BW 
change. Because of these circumstances, the 
interim ADG, DMI, and feedlgain were not useful 
for explaining differences in marbling scores 
attributable to implant treatment. When intake 
was re-evaluated as DMI, glkg BW" the only 
distinctive separation that occurred was much 
lower relative DM1 for non-implanted steers. 
This response began to appear after 112 d on 
feed (Figure 1). 
To further evaluate implant payout, the 
energy density of live weight gain (EDo) was 
calculated as NE, (Mcal)llive weight gain (Ib). 
Higher EDo values would be indicative of higher 
fat content in live weight gain. The N L  and NE, 
intakes used were based upon tabular values for 
feedstuffs and actual feed ingredient intakes. 
Maintenance requirements were calculated 
based upon the mean BW for each pen during 
interim periods. The N L  requirement was 
estimated to be increased by 10% during 
exposure to E2TBA implants (Birkelo, personal 
communication). The final period was averaged 
to 138 d on feed. 
During the initial 56 d EDo was lower (Pc.05) 
in steers exposed to E2TBA. Ralgro caused only 
a slight numerical decline from control values 
during this period. The EDo content of re- 
implanted steers converged with the d-1 E2TBA 
treatments during the 57 to 89 d and 90 to 112 d 
periods. The EDo of nonimplanted steers 
continued to climb and create an increasingly 
wider separation from values for implanted 
steers. 
During the final feeding period, the EDo was 
lower (Pc.05) for re-implanted steers than for 
either d-1 E2TBA treatment. This followed a 137- 
d payout for the d-1 E2TBA treatments. 'The 
E2TBA implant payout for the re-implant 
treatment was only 81 d at this point. The 
difference in EDG reflects more active implant 
activity at this late date and is consistent with 
expectations of implant responses over time. 
If the deposition of fat as marbling is most 
pronounced late in the feeding period, the EDo 
curves suggest that marbling would be highest 
in the nonimplanted steers and lowest in the re- 
implanted steers. Consistent with this concept, 
marbling scores were highest (Pc.001) for the 
nonimplanted steers. However, marbling scores 
were higher (Pc.05) for the re-implanted steers 
than for those on the d-1 E2TBA treatments. 
When the pattern of EDo is compared with the 
ranking by marbling scores, it is the early EDo 
values that best matched the rank of marbling 
scores. The EDo was higher through 56 d for 
those treatments causing higher marbling 
scores. The separation that occurred between 
the nonimplant and re-implant treatments at d 89 
may be indicative of the phase of growth when 
marbling scores among re-implanted steers was 
depressed. 
Conclusions 
Actual payout optimums for implants were 
not defined by this research. In Group I it 
appeared that Synovex Plus was more potent at 
130 d than was revalor-S. This observation was 
reversed in the Group II replication. 
Cumulative feedlot production costs would 
be comparable for the implants used in that 
weight gain and DM1 were similar among 
implanted steers. There is an additional cost 
associated with re-implanting (treatment 4). 
This cost may be offset by the increased 
carcass value associated with this strategy in 
the Group II steers in some fed cattle pricing 
mechanisms. The explanation for improved 
grading associated with re-implanting may relate 
to fewer total days of TBA exposure. However, 
an evaluation of gain energy density suggested 
that it may be the influence of implants early in 
the feeding period that has the greatest effect on 
marbling scores. Theoretically this influence 
may be lessened in cattle carrying more flesh 
when placed in the feedlot. This (along with 
genetics) would help explain why the Choice 
percentage can vary dramatically among cattle 
receiving the same implant strategy. 
Consideration of this aspect of growth would be 
important in determining optimum management 
of implants. Future studies may reveal that 
Choice percentage may be dictated more so by 
the existing body condition when E,TBA 
implants are administered than by the days from 
implanting to harvest. 
Table 1. Diets Fed 
Step 1 Step 2 Step 3 Step 4 Step 5 Step 5' 
% DM basis 
Corn silage 55.00 35.00 25.00 15.00 10.00 - 
Oat silage - - - - - 8.00 
Whole shelled corn 26.65 40.65 47.65 54.65 57.65 59.65 
High moisture corn 9.75 15.75 18.00 21 .OO 23.00 23.00 
~ ~ 4 6 0 ~  3.50 3.50 4.25 4.25 4.25 4.25 
Soybean meal, 44%' 5.00 5.00 5.00 5.00 5.00 5.00 
LimestoneC .10 .10 .10 .10 .10 .10 
'Switch occurred on August 20, 1996. 
b70% DM, contained 460 g MonensinK AFB. Diet provided 28.5 g Monensi f l  DMB. 
'Fed as a pelleted supplement that included tylosin. Diet provided 11 g tylosinK DMB. 
Table 2. Processing schedule 
Group I Group II 
DOF Date DOF Date Procedure 
-2 April 29 -2 May 21 Allotment weight 
-1 April 30 -1 May 22 Sort to pens 
0 May 1 0 May 23 Initial BW1 
1 May 2 1 May 24 Initial BW2, implant 
28 May 30 28 June 21 BW, palpate implant 
56 June 27 56 July 19 BW, Re-implant (4) 
89 July 30 89 August 21 BW, palpate implant 
112 August 22 112 September 13 BW 
130 September 9 130 October 1 BW 
131 September 10 BW 
1 44 October 15 BW 
145 October 16 BW 
Table 3. Pooled performance summary 
Treatment 
Synovex Ralgro 
Contrast P < 
1vs  2,3vs 
Control 
Initial BW, Ib 721 
1 to 28 d 
BW 28, Ib 839 
ADG, Ib 4.23 
DMI, Ibld 17.54 
FIG 4.23 
29 to 56 d 
BW 56, Ib 953 
ADG, Ib 4.05 
DMI, Ibld 20.82 
FIG 5.15 
57 to 89 d 
BW 89, Ib 1076 
ADG, Ib 3.75 
DMI, lbld 22.27 
FIG 6.01 
90 to 112 d 
BW112,Ib 1136 
ADG, Ib 2.61 
DMI, Ibld 21.52 
FIG 8.59 
113 to 130 d 
BWl30,Ib 1173 
ADG, Ib 2.03 
DMI, Ibld 20.14 
FIG 11.14 
90 to 130 d 
ADG, Ib 2.36 
DMI, Ibld 20.90 
FIG 9.02 
Plus 
72 1 
Table 3. Pooled performance summary (con't) 
Treatment Contrast P < 
Synovex revalor- Ralgro 1 vs 2,3 
Control Plus S revalor- S SEM 2,3,4 vs 4 2 vs 3 Trt'Grp 
Early (1 to 56 d) 
ADG, Ib 4.14 5.02 4.84 4.48 .073 .001 .001 .095 NS 
DMI, Ibld 19.18 19.77 19.47 19.60 ,244 .I35 NS NS NS 
FIG 4.65 3.95 4.05 4.40 ,044 .001 .001 NS .029 
Late (57 to end) 
ADG, Ib 2.89 3.66 3.71 3.92 .073 .001 .012 NS .OW 
DMI, Ibld 21.41 23.66 23.47 23.51 .233 .001 NS NS .053 
FIG 7.49 6.49 6.34 6.00 .A14 .001 .006 NS .001 
Cumulative 
Final B W ~ ,  Ib 1191 1301 1298 1296 6.1 .001 NS NS .007 
ADG, Ib 3.14 3.92 3.88 3.86 .039 .001 NS NS .001 
DMI, lbld 20.51 22.07 21.85 21.93 .200 .001 NS NS NS 
FIG 6.56 5.63 5.63 5.69 .050 .001 NS NS .001 
'P>. 15. 
b Final BW includes a 3% shrink. 
Table 4. Interactions between im~lant and group 
Treatment Contrast P < 
Ralgro 
Control Svnovex revalor-S revalor-S 1 vs 2.3 
(1 ) plus (2) (3) (4) SEM 2,3,4 vs 4 2 vs 3 Trt*Grp 
Late (56 to end) 
ADG, Ib 
Group I 2.63 3.81 3.65 3.85 .073 .001 .012 NSa .004 
Group II 3.15 3.50 3.78 4.00 
DMI, Ibld 
Group I 21.23 24.26 23.80 23.30 .233 .001 NS NS .053 
Group II 21.59 23.06 23.14 23.72 
FIG 
Group I 8.09 6.37 6.53 6.07 .A14 .001 .006 NS .001 
Group II 6.88 6.60 6.14 5.94 
Cumulative 
ADG, Ib 
Group I 2.93 3.95 3.75 3.68 .039 .001 NS NS .001 
Group II 3.35 3.89 4.01 4.04 
DMI, lbld 
Group I 20.47 22.41 22.18 21.79 .200 .001 NS NS NS 
Group II 20.56 21.73 21.52 22.06 
FIG 
Group I 6.98 5.68 5.91 5.92 .050 .001 NS NS .001 
Group II 6.14 5.59 5.36 5.46 
'NS indicates P>.15. 
Table 5. Effect of im~lant treatment on carcass traits 
Treatment Contrast P c 
Synovex Ralgro 
Control Plus revalor-S revalor-S 1vs 2,3vs 2vs 
(1 ) (2) (3) (4) SEM 2,3,4 4 3 Trt'Grp 
HCW, Ib 71 7 78 1 785 78 1 5.8 ,001 NS' NS .I39 
Dressing % 62.10 61.85 62.35 62.17 ,161 NS NS ,028 NS 
REA, in2 12.77 13.86 13.82 13.64 135 .001 NS NS NS 
Ribfat, in. .385 .394 .419 .390 .014 NS NS NS NS 
Marblinga 5.37 4.90 5.02 5.17 .082 .001 .026 NS NS 
Bone maturityb 133 145 146 149 1.7 .001 ,114 NS NS 
Lean maturityc 141 139 136 141 1.6 NS .054 NS NS 
~ascul in i ty~ .63 .96 1.03 1.05 .060 .001 NS NS .002 
% Choice' 68.4 43.0 51 .O 59.6 
 
bclOO = A0 ; 200 = BO. 
d scale 0 to 3; 3 = stag. 
'~=.002 by Chi square analysis. 
'NS indicates P>.15. 
Table 6. Marblina scores and ~ercentaae Choice bv im~lant x arouD 
Treatment 
Ralgro - 
Control Synovex Plus revalor-S revalor-S X 
l tem (1 ) (2) (3) (4) 
 arbl ling'^ Group I 5.52 4.95 5.13 5.19 5.20 
Group II 5.21 4.85 4.90 5.16 5.03 
Choice, %* Group I 67.4 54.0 58.0 59.2 59.6 
Group II 69.4 32.0 44.0 60.0 51.3 
~ibfat', in Group I .414 .430 .470 .418 .433 
Group II .356 .357 .369 .362 .361 
'Treatment effect (P<.OOl). 
b Group effect (P<.o~). 
Vreatment effect (P=.002). 
d ~ r o u p  effect (P=.09). 
'Group effect (P<.OOl). 
